AMGN vs CLX · P/E 24, rev $10.05B vs P/E 15, rev $7.10B
Amgen Inc (AMGN) versus The Clorox Company (CLX) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
The Clorox Company (CLX) is a household & personal products company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported CLX revenue for 2025-06-30 was $7.10B. Net income was $824.0M. CLX currently screens at market cap $10.89B and trailing P/E 14.6.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. CLX currently screens at market cap $10.89B and trailing P/E 14.6.
Not investment advice. Open the AMGN and CLX stock pages for the full models.
Not investment advice.